In the realm of pharmaceuticals and public health, trust is paramount. When individuals consent to receiving vaccinations, they place their faith in the system, believing that these interventions are safe and effective. However, history has shown that this trust can be betrayed, sometimes with devastating consequences. One such case involves Wyeth, now merged with Pfizer, and their adoption of the infamous “small batch rule” following a tragic incident in 1979.
Presidential candidate Robert F Kennedy Jr brought this account to the forefront recently on X, when he posted that “This is the incident that caused Wyeth (now Pfizer) to adopt the “small batch rule,” an internal directive to break up batches among different regions so that the “hot” batches would not all end up in one city where a cluster of deaths would attract notice. CDC also initiated its own policy to keep the SIDS link to DTP vaccines undetected. CDC broke up SIDS into several new diagnostic sub categories including SUID and SUDC to conceal the explosion in SIDS cases from the public.”
The story begins in a county in Tennessee, where eleven infants tragically succumbed to Sudden Infant Death Syndrome (SIDS) within a short period. What connected these heartbreaking deaths was not just their proximity in time and location, but also the fact that all these babies had received the same vaccine from the same batch. This alarming correlation raised red flags and demanded urgent investigation and action.
However, what followed was not transparency and accountability but rather a disturbing cover-up orchestrated by Wyeth, the pharmaceutical company responsible for manufacturing the vaccine in question. Instead of initiating a recall and launching a thorough investigation into the safety of the vaccine, Wyeth chose to conceal the issue. Their response was twofold: first, they suppressed information about the deaths associated with their vaccine, and second, they implemented what came to be known as the “small batch rule.”
The small batch rule was an internal directive within Wyeth that mandated the distribution of vaccine batches across different regions. The rationale behind this directive was chillingly pragmatic: by dispersing the batches geographically, any future clusters of adverse events, such as deaths or severe reactions, would not attract attention or scrutiny. In essence, it was a calculated strategy to avoid detection and accountability for potentially harmful products.
This strategy speaks volumes about the priorities of pharmaceutical companies when faced with crises of public health and safety. Rather than prioritizing the well-being of consumers and addressing the root cause of adverse events, companies like Wyeth prioritized their reputation and bottom line. The decision to implement the small batch rule was not motivated by a commitment to public health but rather by a desire to protect profits and evade regulatory scrutiny.
Equally troubling is the role played by regulatory agencies, particularly the Centers for Disease Control and Prevention (CDC), in obscuring the link between vaccines and adverse events. In the case of SIDS, the CDC initiated policies to fragment the diagnosis into several subcategories, such as Sudden Unexpected Infant Death (SUID) and Sudden Unexplained Death in Childhood (SUDC). By diluting the classification of SIDS, the CDC effectively obscured the true extent of the issue, making it more difficult for researchers and the public to identify patterns and correlations between vaccines and adverse events.
The ramifications of these actions extend far beyond the immediate victims and their families. They erode trust in public health institutions, sow doubt about the safety of vaccines, and perpetuate a culture of secrecy and deception within the pharmaceutical industry. Moreover, they underscore the urgent need for transparency, accountability, and independent oversight in the development, manufacturing, and distribution of vaccines and other medical products.
As we reflect on this dark chapter in the history of vaccine safety, we must remain vigilant and demand greater transparency and accountability from pharmaceutical companies and regulatory agencies. The lives and well-being of individuals should never be sacrificed at the altar of corporate profits or bureaucratic expediency. Only through unwavering commitment to ethics, integrity, and public health can we hope to prevent similar tragedies in the future.
Given the fact that we cannot trust Big Pharma and the corporate capture of the FDA and CDC, The Wellness Company is creating the parallel medical economy that allows you to take control of your own health. From supplements to emergency medical kits to telehealth services, they have it all. Use code JEFF for 10% off of anything. Click here to order.